We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
PRI Near 52-Week High: Should You Add the Stock to Your Portfolio Now?
Read MoreHide Full Article
Shares of Primerica Inc. (PRI - Free Report) closed at $263.34 on Tuesday, near a 52-week high of $265.67. A compelling portfolio, strong market presence and solid capital position are driving the share price higher.
This second-largest issuer of term-life insurance coverage in North America envisions being a successful senior health business while continuing to enhance its shareholders’ value. PRI’s earnings have risen 17.6% in the past five years, outperforming the industry average of 4.6%.
Shares of PRI have gained 11.6% in the past three months, outperforming the industry’s growth of 11.4%, the Finance sector’s increase of 2.7% and the Zacks S&P 500 composite’s increase of 3.9%.
PRI shares are trading well above the 50-day moving average, indicating a bullish trend.
Average Target Price for PRI Suggests an Upside
Based on short-term price targets offered by five analysts, the Zacks average price target is at $275.20 per share. The average suggests a potential 4.5% upside from Tuesday’s closing price.
Upbeat Analyst Sentiments
Four of the six analysts covering the stock have raised estimates for 2024 and 2025 over the past 60 days. The consensus estimate for 2024 and 2025 has moved 1.2% and 1.6%, respectively, in the past 60 days.
The Zacks Consensus Estimate for 2024 implies an 11.7% year-over-year increase, while the same for 2025 suggests an 11.5% increase.
Return on Capital
Return on equity (ROE), a profitability measure to identify how efficiently a company is utilizing its shareholders’ funds, has been improving over the last several years. PRI’s trailing 12-month ROE of 27.8% is better than the industry average of 15.5%.
Also, the return on invested capital in the trailing 12 months was 7.2%, better than the industry average of 0.7%, reflecting PRI’s efficiency in utilizing funds to generate income.
Factors Favoring PRI
Primerica’s solid business model makes it well-poised to cater to the middle market's increased demand for financial security. Nearly 48% of middle-income Americans are ready for retirement based on their investment and savings habits. A compelling portfolio and a strong lineup of life-licensed sales representatives will poise PRI to capitalize on the opportunities.
Management estimates more than a 5% rise in sales force size in 2024. This should help cater to an estimated number of Term Life policies growth in low single digits and about 15% in Investment and Savings Products sales.
The life insurer has also decided to exit the senior health market as it believes this business will not be able to return the desired value for shareholders, given a challenging senior health distribution market. This will help PRI channel resources to businesses that will accelerate growth.
Primerica has a solid balance sheet, courtesy of improving leverage ratio and solid liquidity. It also scores strongly with credit rating agencies.
The strength of its Term-life insurance business ensures consistent free cash flow. Notably, its free cash flow conversion has remained more than 100% over the last many quarters, reflecting solid earnings.
Banking on operational expertise, the life insurer raises dividends each year as well as buys back shares. It increased dividends at a 10-year CAGR of 16.8%. It also has $173.2 million worth of shares remaining under authorization.
PRI Capital Shares Are Overvalued
PRI shares are trading at a price-to-book multiple of 4.27, higher than the industry average of 1.94.
Shares of other insurers like The Allstate Corporation (ALL - Free Report) are trading at a multiple higher than the industry average, while shares of MetLife Inc. (MET - Free Report) and American International Group, Inc. (AIG - Free Report) are trading at a multiple lower than the industry average.
Conclusion
Strong demand for protection products ensures sales growth and policy persistency. Primerica thus has upside potential backed by its solid growth prospects and financial health.
Despite its premium valuation, this Zacks Rank #2 (Buy) life insurer is worth adding to an investor’s portfolio.
Image: Bigstock
PRI Near 52-Week High: Should You Add the Stock to Your Portfolio Now?
Shares of Primerica Inc. (PRI - Free Report) closed at $263.34 on Tuesday, near a 52-week high of $265.67. A compelling portfolio, strong market presence and solid capital position are driving the share price higher.
This second-largest issuer of term-life insurance coverage in North America envisions being a successful senior health business while continuing to enhance its shareholders’ value. PRI’s earnings have risen 17.6% in the past five years, outperforming the industry average of 4.6%.
Shares of PRI have gained 11.6% in the past three months, outperforming the industry’s growth of 11.4%, the Finance sector’s increase of 2.7% and the Zacks S&P 500 composite’s increase of 3.9%.
PRI shares are trading well above the 50-day moving average, indicating a bullish trend.
Average Target Price for PRI Suggests an Upside
Based on short-term price targets offered by five analysts, the Zacks average price target is at $275.20 per share. The average suggests a potential 4.5% upside from Tuesday’s closing price.
Upbeat Analyst Sentiments
Four of the six analysts covering the stock have raised estimates for 2024 and 2025 over the past 60 days. The consensus estimate for 2024 and 2025 has moved 1.2% and 1.6%, respectively, in the past 60 days.
The Zacks Consensus Estimate for 2024 implies an 11.7% year-over-year increase, while the same for 2025 suggests an 11.5% increase.
Return on Capital
Return on equity (ROE), a profitability measure to identify how efficiently a company is utilizing its shareholders’ funds, has been improving over the last several years. PRI’s trailing 12-month ROE of 27.8% is better than the industry average of 15.5%.
Also, the return on invested capital in the trailing 12 months was 7.2%, better than the industry average of 0.7%, reflecting PRI’s efficiency in utilizing funds to generate income.
Factors Favoring PRI
Primerica’s solid business model makes it well-poised to cater to the middle market's increased demand for financial security. Nearly 48% of middle-income Americans are ready for retirement based on their investment and savings habits. A compelling portfolio and a strong lineup of life-licensed sales representatives will poise PRI to capitalize on the opportunities.
Management estimates more than a 5% rise in sales force size in 2024. This should help cater to an estimated number of Term Life policies growth in low single digits and about 15% in Investment and Savings Products sales.
The life insurer has also decided to exit the senior health market as it believes this business will not be able to return the desired value for shareholders, given a challenging senior health distribution market. This will help PRI channel resources to businesses that will accelerate growth.
Primerica has a solid balance sheet, courtesy of improving leverage ratio and solid liquidity. It also scores strongly with credit rating agencies.
The strength of its Term-life insurance business ensures consistent free cash flow. Notably, its free cash flow conversion has remained more than 100% over the last many quarters, reflecting solid earnings.
Banking on operational expertise, the life insurer raises dividends each year as well as buys back shares. It increased dividends at a 10-year CAGR of 16.8%. It also has $173.2 million worth of shares remaining under authorization.
PRI Capital Shares Are Overvalued
PRI shares are trading at a price-to-book multiple of 4.27, higher than the industry average of 1.94.
Shares of other insurers like The Allstate Corporation (ALL - Free Report) are trading at a multiple higher than the industry average, while shares of MetLife Inc. (MET - Free Report) and American International Group, Inc. (AIG - Free Report) are trading at a multiple lower than the industry average.
Conclusion
Strong demand for protection products ensures sales growth and policy persistency. Primerica thus has upside potential backed by its solid growth prospects and financial health.
Despite its premium valuation, this Zacks Rank #2 (Buy) life insurer is worth adding to an investor’s portfolio.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.